Clinical Trial Update: Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia [Phase 3]

View source ↗

Summary

Phase 3 safety and effectiveness study of the VEGA UV-A System for corneal cross-linking in keratoconus and ectasia; study terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ectasia
• Keratoconus

Drugs mentioned

• VEGA UV-A System

Snippet

Sponsor: Topcon Medical Systems, Inc. | Conditions: Keratoconus and Ectasia | Phase 3 | Status: TERMINATED | Results posted: 2013-03-04